APA

Wong K. S. L., Chen C., Fu J., Chang H. M., Suwanwela N. C., Huang Y. N., Han Z., Tan K. S., Ratanakorn D., Chollate P., Zhao Y., Koh A., Hao Q. & Markus H. S. (20100503). Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. : The Lancet. Neurology.

Chicago

Wong Ka Sing Lawrence, Chen Christopher, Fu Jianhui, Chang Hui Meng, Suwanwela Nijasri C, Huang Yining N, Han Zhao, Tan Kay Sin, Ratanakorn Disya, Chollate Pavithra, Zhao Yudong, Koh Angeline, Hao Qing and Markus Hugh S. 20100503. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. : The Lancet. Neurology.

Harvard

Wong K. S. L., Chen C., Fu J., Chang H. M., Suwanwela N. C., Huang Y. N., Han Z., Tan K. S., Ratanakorn D., Chollate P., Zhao Y., Koh A., Hao Q. and Markus H. S. (20100503). Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. : The Lancet. Neurology.

MLA

Wong Ka Sing Lawrence, Chen Christopher, Fu Jianhui, Chang Hui Meng, Suwanwela Nijasri C, Huang Yining N, Han Zhao, Tan Kay Sin, Ratanakorn Disya, Chollate Pavithra, Zhao Yudong, Koh Angeline, Hao Qing and Markus Hugh S. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. : The Lancet. Neurology. 20100503.